📊 LFVN Key Takeaways
Is Lifevantage Corp (LFVN) a Good Investment?
Lifevantage demonstrates revenue growth and improved net income, but exhibits severe cash generation weakness with negative free cash flow (-$1.0M) despite profitability, indicating earnings quality concerns. Extremely thin operating margins (2.9%) and operating cash flow conversion of only 0.5% of revenue create sustainability risks.
Lifevantage is posting double‑digit revenue growth with a very strong gross margin and a debt‑free balance sheet, indicating improving fundamentals and financial resilience. Yet profitability remains thin and free cash flow is negative, signaling that earnings quality and working‑capital discipline must improve. Sustained margin expansion and conversion of earnings to cash are needed before a more constructive stance.
Why Buy Lifevantage Corp Stock? LFVN Key Strengths
- Strong gross margins at 76.7% demonstrate pricing power and cost efficiency
- Zero long-term debt and debt-to-equity ratio of 0.00x provide robust financial flexibility
- Revenue growth of 14.2% year-over-year shows market demand and top-line momentum
- Debt‑free balance sheet with solid liquidity (current ratio 2.03x)
- High gross margin of 76.7% indicating strong unit economics
- Revenue and net income growing YoY (+14.2% revenue, profitability rebound)
LFVN Stock Risks: Lifevantage Corp Investment Risks
- Negative free cash flow of -$1.0M despite positive net income signals earnings quality issues and potential unsustainable profitability
- Operating cash flow of only $486K represents just 0.5% of $96.5M revenue, indicating poor cash conversion
- Razor-thin operating margin of 2.9% and net margin of 2.5% leave no margin for error in execution or market conditions
- Negative free cash flow and weak operating cash generation
- Thin operating margin (2.9%) leaves little cushion for shocks
- Potential working‑capital volatility creating earnings-to-cash flow disconnect
Key Metrics to Watch
- Operating cash flow trend and cash conversion ratio - must demonstrate positive trend to validate profitability
- Free cash flow sustainability and working capital management efficiency
- Operating margin expansion capability - growth must translate to margin improvement
- Operating cash flow
- Operating margin
Lifevantage Corp (LFVN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.03x current ratio provides a solid financial cushion.
LFVN Profit Margin, ROE & Profitability Analysis
LFVN vs Healthcare Sector: How Lifevantage Corp Compares
How Lifevantage Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Lifevantage Corp Stock Overvalued? LFVN Valuation Analysis 2026
Based on fundamental analysis, Lifevantage Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Lifevantage Corp Balance Sheet: LFVN Debt, Cash & Liquidity
LFVN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Lifevantage Corp's revenue has remained relatively flat over the 5-year period, with a 2% decline. The most recent EPS of $0.23 reflects profitable operations.
LFVN Revenue Growth, EPS Growth & YoY Performance
LFVN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $48.9M | $276.0K | $0.02 |
| Q1 2026 | $47.2M | $1.8M | $0.14 |
| Q3 2025 | $48.2M | $629.0K | $0.13 |
| Q2 2025 | $51.6M | -$27.0K | $0.00 |
| Q1 2025 | $47.2M | $629.0K | $0.05 |
| Q3 2024 | $48.2M | $574.0K | $0.05 |
| Q2 2024 | $51.6M | -$27.0K | $0.00 |
| Q1 2024 | $51.4M | $610.0K | $0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Lifevantage Corp Dividends, Buybacks & Capital Allocation
LFVN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Lifevantage Corp (CIK: 0000849146)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LFVN
What is the AI rating for LFVN?
Lifevantage Corp (LFVN) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 67% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are LFVN's key strengths?
Claude: Strong gross margins at 76.7% demonstrate pricing power and cost efficiency. Zero long-term debt and debt-to-equity ratio of 0.00x provide robust financial flexibility. ChatGPT: Debt‑free balance sheet with solid liquidity (current ratio 2.03x). High gross margin of 76.7% indicating strong unit economics.
What are the risks of investing in LFVN?
Claude: Negative free cash flow of -$1.0M despite positive net income signals earnings quality issues and potential unsustainable profitability. Operating cash flow of only $486K represents just 0.5% of $96.5M revenue, indicating poor cash conversion. ChatGPT: Negative free cash flow and weak operating cash generation. Thin operating margin (2.9%) leaves little cushion for shocks.
What is LFVN's revenue and growth?
Lifevantage Corp reported revenue of $96.5M.
Does LFVN pay dividends?
Lifevantage Corp pays dividends, with $1.1M distributed to shareholders in the trailing twelve months.
Where can I find LFVN SEC filings?
Official SEC filings for Lifevantage Corp (CIK: 0000849146) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LFVN's EPS?
Lifevantage Corp has a diluted EPS of $0.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is LFVN a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Lifevantage Corp has a SELL rating with 67% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is LFVN stock overvalued or undervalued?
Valuation metrics for LFVN: ROE of 7.4% (sector avg: 15%), net margin of 2.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy LFVN stock in 2026?
Our dual AI analysis gives Lifevantage Corp a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LFVN's free cash flow?
Lifevantage Corp's operating cash flow is $486.0K, with capital expenditures of $1.5M. FCF margin is -1.1%.
How does LFVN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 2.5% (avg: 12%), ROE 7.4% (avg: 15%), current ratio 2.03 (avg: 2).